Table 1.
Factors altering microbiota homeostasis during allo-HSCT and proposed therapies targeting restoration in intestinal microbial diversity
| Dysbiosis (→ Inflammation/epithelial damage) |
Eubiosis (→ Immune regulation/epithelial restoration) |
|---|---|
| GVHD | Growth factors (KGF) |
| Conditioning chemotherapy/irradiation | Probiotics (Lactobacillus) |
| Antimicrobial therapy | Cellular therapy (ISC, MSC) |
| Alloreactivity | Cytokines (IL-22) |
| Supplemental nutrition (intralipids) | SCFA (butyrate/acetate) |
| Mucositis | Polysaccharide A/vitamin A |
| Infection (viral/bacterial) | Antimicrobial peptides (REGIIIα) |
| Reduced intensity conditioning | |
| Narrow-spectrum antimicrobials |